Epidermal growth factor receptor

Current Opinion in Neurology - Tập 25 Số 6 - Trang 774-779 - 2012
Monika E. Hegi1,2,3,4,5, Premnath Rajakannu1, Michael Weller6
1Laboratory of Brain Tumor Biology and Genetics, Service of Neurosurgery, Department of Clinical Neurosciences, University Hospital Lausanne
2National Center of Competence Research Molecular Oncology, ISREC, SV-EPFL, Lausanne
3e-mail: [email protected]
4fax: +41 21 314 2587
5to Monika E. Hegi, Laboratory of Brain Tumor Biology and Genetics, BH19-110, University Hospital Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland. Tel: +41 21 314 2582
6Department of Neurology, University Hospital Zurich, and Neuroscience Center, University of Zurich, Zurich, Switzerland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ohgaki, 2007, Am J Pathol, 170, 1445, 10.2353/ajpath.2007.070011

Verhaak, 2010, Cancer Cell, 17, 98, 10.1016/j.ccr.2009.12.020

Hegi, 2012, Acta Neuropathol, 123, 841, 10.1007/s00401-011-0938-4

Hegi, 1997, Int J Cancer, 73, 57, 10.1002/(SICI)1097-0215(19970926)73:1<57::AID-IJC10>3.0.CO;2-2

Yan, 2009, N Engl J Med, 360, 765, 10.1056/NEJMoa0808710

Brennan, 2009, PLoS One, 4, e7752, 10.1371/journal.pone.0007752

Mendelsohn, 2000, Oncogene, 19, 6550, 10.1038/sj.onc.1204082

Lynch, 2004, N Engl J Med, 350, 2129, 10.1056/NEJMoa040938

Paez, 2004, Science, 304, 1497, 10.1126/science.1099314

Frederick, 2000, Cancer Res, 60, 1383

Lee, 2006, PLoS Med, 3, e485, 10.1371/journal.pmed.0030485

Vivanco, 2012, Cancer Discov, 2, 458, 10.1158/2159-8290.CD-11-0284

Ekstrand, 1991, Cancer Res, 51, 2164

Nishikawa, 1994, Proc Natl Acad Sci U S A, 91, 7727, 10.1073/pnas.91.16.7727

Huang, 2009, Sci Signal, 2, re6, 10.1126/scisignal.287re6

Kuan, 2001, Endocr Relat Cancer, 8, 83, 10.1677/erc.0.0080083

Sampson, 2010, J Clin Oncol, 28, 4722, 10.1200/JCO.2010.28.6963

Pines, 2010, Oncogene, 29, 5850, 10.1038/onc.2010.313

Cho, 2011, Cancer Res, 71, 7587, 10.1158/0008-5472.CAN-11-0821

Vivanco, 2010, Curr Opin Oncol, 22, 573, 10.1097/CCO.0b013e32833edbdf

Yung, 2010, Neuro Oncol, 12, 1061, 10.1093/neuonc/noq072

Rich, 2004, J Clin Oncol, 22, 133, 10.1200/JCO.2004.08.110

van den Bent, 2009, J Clin Oncol, 27, 1268, 10.1200/JCO.2008.17.5984

Thiessen, 2010, Cancer Chemother Pharmacol, 65, 353, 10.1007/s00280-009-1041-6

Brandes, 2008, Clin Cancer Res, 14, 957, 10.1158/1078-0432.CCR-07-1810

Sarkaria, 2007, Mol Cancer Ther, 6, 1167, 10.1158/1535-7163.MCT-06-0691

Peereboom, 2010, J Neurooncol, 98, 93, 10.1007/s11060-009-0067-2

Hegi, 2011, Mol Cancer Ther, 10, 1102, 10.1158/1535-7163.MCT-11-0048

Citri, 2006, Nat Rev Mol Cell Biol, 7, 505, 10.1038/nrm1962

Amit, 2007, Nat Genet, 39, 503, 10.1038/ng1987

Stommel, 2007, Science, 318, 287, 10.1126/science.1142946

Reardon, 2010, J Neurooncol, 96, 219, 10.1007/s11060-009-9950-0

Lv, 2012, Int J Oncol, 41, 1029, 10.3892/ijo.2012.1539

Westphal, 2012, J Clin Oncol, 30, 2033, 10.1200/JCO.2012.42.3285

Choi, 2009, Brain Pathol, 19, 713, 10.1111/j.1750-3639.2009.00318.x

da Cunha Santos, 2011, Annu Rev Pathol, 6, 49, 10.1146/annurev-pathol-011110-130206

Barkovich, 2012, Cancer Discov, 2, 450, 10.1158/2159-8290.CD-11-0287

Huang, 2007, Cell Cycle, 6, 2750, 10.4161/cc.6.22.4922

Tanaka, 2011, Cancer Discov, 1, 524, 10.1158/2159-8290.CD-11-0124

Cvrljevic, 2011, J Cell Sci, 124, 2938, 10.1242/jcs.083295

Lu, 2009, Cancer Res, 69, 6889, 10.1158/0008-5472.CAN-09-0347

Huang, 2007, Proc Natl Acad Sci U S A, 104, 12867, 10.1073/pnas.0705158104